Biotech Values

[DewDiligence]

Another private company with a similar claim:

https://www.globenewswire.com/news-release/2025/05/07/3076030/0/en/Valitor-Presents-Multiple-Preclinical-Datasets-on-the-Potential-of-its-Innovative-Anti-VEGF-Therapy-Dosed-Twice-Yearly-for-Wet-AMD-at-the-Association-for-Research-in-Vision-and-Oph.html